Monday, January 30, 2017 7:45:05 PM
The report/company did not clearly state that.
The report actually stated ..
"Upon completion of the mass production run, the company expects full approval and industry testing to be completed within a 4 to 6 weeks timeframe."
Interestingly, the report stated in the paragraph directly above that quote ..
"..the company is expecting the new card to be out of mass production over the next six weeks."
Every person I spoke with who read that report interpreted the words as meaning the company is waiting 6 weeks for mass production, then another 6 weeks for approval in testing. Words from the report!
It would seem to me that 6 weeks plus 6 weeks equals 12 weeks. Again, the company is not clearly stating anything, but merely putting out material that may be interpreted one way or another depending on one's attitude. Historically the company has accused readers of misinterpreting information when timelines have not been met, or when release of a product to market actually meant testing the market with a limited release.
We all seek your clarification. Is it 6 weeks or 12 weeks? Or even something else?
While we are it seeking clarification.... does the company know of any other likely impediments to the mass production run? Is there likely to be another small component part that might need to be found and exchanged at the last minute, thus preventing or delaying actual positive news? Are we likely to hear of another problem in 6 weeks?
I ask the question because I have been preparing for my 17th birthday of late. Yep, next month I will celebrate my 17th anniversary of investing with this company (including various iterations of its predecessors). As you would know, there have been many times that we have been on the edge of success and then told that there was a widget or inappropriate bezel that got in the way.
Recent SMME News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/21/2024 06:41:03 PM
- Credit Card to Prevent Fraudulent Activities • AllPennyStocks.com • 12/21/2023 08:00:00 PM
- Credit Card to Prevent Fraudelent Activities • AllPennyStocks.com • 12/21/2023 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 11:00:48 AM
- Form 253G1 - • Edgar (US Regulatory) • 11/06/2023 04:10:16 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 11/06/2023 05:15:06 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:26:28 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/19/2023 08:20:09 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/18/2023 09:26:13 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 10/16/2023 10:00:11 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:58:03 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/27/2023 07:27:47 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 09/26/2023 11:39:30 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM